Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma.

about

Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice.

P2860

Q30249083-76278040-A6E5-4E64-8834-5D8BB3B77F06

P2860

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q40588449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Impact of time from diagnosis ...... th classical Hodgkin lymphoma.

@en

type

Item

label

Impact of time from diagnosis ...... th classical Hodgkin lymphoma.

@en

prefLabel

Impact of time from diagnosis ...... th classical Hodgkin lymphoma.

@en

P1476

Impact of time from diagnosis ...... th classical Hodgkin lymphoma.

@en

P2093

Alina S Gerrie

http://www.w3.org/2001/XMLSchema#string

Brian Skinnider

http://www.w3.org/2001/XMLSchema#string

Diego Villa

http://www.w3.org/2001/XMLSchema#string

Edward G Brooks

http://www.w3.org/2001/XMLSchema#string

Graham W Slack

http://www.w3.org/2001/XMLSchema#string

Kerry J Savage

http://www.w3.org/2001/XMLSchema#string

Laurie H Sehn

http://www.w3.org/2001/XMLSchema#string

Richard Klasa

http://www.w3.org/2001/XMLSchema#string

Tamara N Shenkier

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.

ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.

P304

872-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1086919

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph M Connors

Randy D Gascoyne

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26325236

http://www.w3.org/2001/XMLSchema#string

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma.

about

P2860

P2860

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698